Abstract 2098: NVP-FGF401, a first-in-class highly selective and potent FGFR4 inhibitor for the treatment of HCC | Citedby Results | Cancer Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Abstract 2098: NVP-FGF401, a first-in-class highly selective and potent FGFR4 inhibitor for the treatment of HCC

Cancer Res (2017) 77 (13_Supplement): 2098.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Pyrrolo[2,3-b]pyridine-3-one derivatives as novel fibroblast growth factor receptor 4 inhibitors for the treatment of hepatocellular carcinoma

Qiaomei Jin
Dongjian Zhang
Meng Gao
Cuihua Jiang
Jian Zhang

Bioorganic & Medicinal Chemistry (2021) 29: 115862.

Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients

Christian Gampe
Vishal A. Verma

Journal of Medicinal Chemistry (2020) 63 (23): 14357.

FGFR4: A promising therapeutic target for breast cancer and other solid tumors

Kevin M. Levine
Kai Ding
Lyuqin Chen
Steffi Oesterreich

Pharmacology & Therapeutics (2020) 214: 107590.

Fibroblast Growth Factor Receptor 4 (FGFR4) Selective Inhibitors as Hepatocellular Carcinoma Therapy: Advances and Prospects

Xiaoyun Lu
Hao Chen
Adam V. Patterson
Jeff B. Smaill
Ke Ding

Journal of Medicinal Chemistry (2019) 62 (6): 2905.

Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors

Shuyan Dai
Zhan Zhou
Zhuchu Chen
Guangyu Xu
Yongheng Chen

Cells (2019) 8 (6): 614.

2-Formylpyridyl Ureas as Highly Selective Reversible-Covalent Inhibitors of Fibroblast Growth Factor Receptor 4

Thomas Knoepfel
Pascal Furet
Robert Mah
Nicole Buschmann
Catherine Leblanc
Sebastien Ripoche
Diana Graus-Porta
Markus Wartmann
Inga Galuba
Robin A. Fairhurst

ACS Medicinal Chemistry Letters (2018) 9 (3): 215.

Structure, activation and dysregulation of fibroblast growth factor receptor kinases: perspectives for clinical targeting

Brendan Farrell
Alexander L. Breeze

Biochemical Society Transactions (2018) 46 (6): 1753.